Our Purpose
The Clinical Proteomics Platform aims to exploit the latest technological developments in mass spectrometry and immunoassay for the discovery, validation and use of biomarkers in various human pathologies (proteins, RNA, DNA, metabolites).
Our Approach
Several technological approaches oriented towards the use of clinical samples and high throughput are available, including mass spectrometry (MRM and HRMS) and ultra-sensitive immunoassays (SIMOA and MSD).
Our Mission
Integrated in the Montpellier Proteome Cluster since its creation and IBiSA labeled, its mission is equally to make medical, biological and technical expertise in Clinical Proteomics available to academic and industrial teams. The PPC has been ISO 9001 certified since 2014.
Latest news :
Doctor Margaux Vignon
Congratulations to Dr Margaux Vignon on the flawless defense of her thesis earlier this week. With her subject "A study of salivary biomarkers of periodontitis", she showed a public interest on doing more in depth research on periodontal medicine. While she's already...
JFSM 2025 in Montpellier
The PPM - Pôle Protéome de Montpellier - is delighted to have been part of the organising team for this 41st edition, that took place in Montpellier. As part of the PPM, several members of our team participated in the conference in different ways: oral presentations,...
RNA Mass Spectrometry training school
Last week, we had the pleasure of hosting the "RNA Mass Spectrometry" training school, organized by the COST Action Translacore. It was a great opportunity to welcome students and scientists from across Europe, and to share our expertise, analytical workflows, and...
The PPC in a nutshell :
Employees
Years of experience
Ongoing projects
Patents
Clinical Proteomics Platform
Institute for Regenerative Medicine & Biotherapy (IRMB)
Hôpital Saint Eloi
80 rue Augustin Fliche
34295 MONTPELLIER – Cedex 5
FRANCE